Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus prospective analysis of a series of 100 patients

dc.contributor.authorCervera i Segura, Ricard, 1960-cat
dc.contributor.authorFont Franco, Josep, 1953-2006cat
dc.contributor.authorLópez-Soto, Alfonsocat
dc.contributor.authorCasals Solé, Francesc J.cat
dc.contributor.authorPallarés Ferreres, Luciocat
dc.contributor.authorBové Boada, Albertocat
dc.contributor.authorIngelmo Morín, Miguelcat
dc.contributor.authorUrbano Márquez, A. (Álvaro)cat
dc.date.accessioned2012-03-05T12:52:05Z
dc.date.available2012-03-05T12:52:05Z
dc.date.issued1990
dc.description.abstractA prospective study of IgG and IgM isotypes of anticardiolipin antibodies (aCL) in a series of 100 patients with systemic lupus erythematosus was carried out. To determine the normal range of both isotype titres a group of 100 normal control serum samples was studied and a log-normal distribution of IgG and IgM isotypes was found. The IgG anticardiolipin antibody serum was regarded as positive if a binding index greater than 2.85 (SD 3.77) was detected and a binding index greater than 4.07 (3.90) was defined as positive for IgM anticardiolipin antibody. Twenty four patients were positive for IgG aCL, 20 for IgM aCL, and 36 for IgG or IgM aCL, or both. IgG aCL were found to have a significant association with thrombosis and thrombocytopenia, and IgM aCL with haemolytic anaemia and neutropenia. Specificity and predictive value for these clinical manifestations increased at moderate and high anticardiolipin antibody titres. In addition, a significant association was found between aCL and the presence of lupus anticoagulant. Identification of these differences in the anticardiolipin antibody isotype associations may improve the clinical usefulness of these tests, and this study confirms the good specificity and predictive value of the anticardiolipin antibody titre for these clinical manifestations.eng
dc.format.extent5 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec43198
dc.identifier.issn0003-4967
dc.identifier.pmid2107799
dc.identifier.urihttps://hdl.handle.net/2445/22438
dc.language.isoengeng
dc.publisherBMJ Group
dc.relation.isformatofReproducció digital del document publicat a: http://dx.doi.org/10.1136/ard.49.2.109
dc.relation.ispartofAnnals of the Rheumatic Diseases, 1990, vol. 49, núm. 2, p. 109-113
dc.relation.urihttp://dx.doi.org/10.1136/ard.49.2.109
dc.rights(c) BMJ Publishing Group Ltd, 1990
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationImmunoglobulinescat
dc.subject.classificationLupus eritematóscat
dc.subject.classificationAssaigs clínicscat
dc.subject.otherImmunoglobulinseng
dc.subject.otherLupus erythematosuseng
dc.subject.otherClinical trialseng
dc.titleIsotype distribution of anticardiolipin antibodies in systemic lupus erythematosus prospective analysis of a series of 100 patientseng
dc.typeinfo:eu-repo/semantics/articleca
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
43198.pdf
Mida:
951.67 KB
Format:
Adobe Portable Document Format